One of the primary motivations fordeveloping TBK1 inhibitors is their potential as anticancer agents.TBK1 has been implicated in promoting tumor growth and progressionin certain types of cancer by enhancing cell survival, proliferation,and metastasis. This evidence concerns the gene TBK1 and cancer.